Zephyrnet Logo

Biotechnology

LeMaitre Vascular Will Announce Second Quarter 2020 Earnings Results on July 23, 2020

BURLINGTON, Mass., July 10, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2020 financial results...

Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study

STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's...

Misonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 Million

Full Year Revenue of Approximately $62.3 Million Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies ...

Extendicare Announces Timing of 2020 Second Quarter Results and Conference Call

MARKHAM, Ontario, July 10, 2020 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial...

Biopharma Giants Back Launch of AMR Fund with $1 Billion

COVID-19 swept across the globe in a matter of months infecting millions of people. With few treatment options currently available, it is a...

Gilead: Remdesivir Demonstrates Broader Effectiveness Against COVID-19

Sonis Photography/Shutterstock Gilead Sciences reported additional data from its Phase III SIMPLE-Severe trial and a real-world retrospective group of patients with severe...

Nkarta Announces Pricing of Initial Public Offering – July 10, 2020

SOUTH SAN FRANCISCO, July 10, 2020 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell...

Blackstone Closes $4.6 Billion Life Sciences Fund

Roman Tiraspolsky / Shutterstock Blackstone announced its Blackstone Life Sciences V fund closed at its hard cap of $4.6 billion of total...

BioNTech CEO Believes COVID-19 Vaccine Could be Ready for Approval by December

BioNTech Chief Executive Officer Ugur Sahin predicts the company’s vaccine for COVID-19, which is it co-developing with Pfizer, could be ready for...

BioSpace Movers & Shakers, July 10

Akcea Therapeutics – William Andrews was named chief medical officer of Akcea Therapeutics, a division of Ionis Pharmaceuticals. Andrews will lead medical,...

BioSpace Movers & Shakers, July 10

Akcea Therapeutics – William Andrews was named chief medical officer of Akcea Therapeutics, a division of Ionis Pharmaceuticals. Andrews will lead medical,...

Biopharma Update on the Novel Coronavirus: July 10

News information is not all-inclusive and updates will now be published on Mondays, Wednesdays and Fridays.  FDA Actions Warning Letter: The FDA...

Latest Intelligence

spot_img
spot_img

Chat with us

Hi there! How can I help you?